Interfering with healing: the benefits of intervention during acute myocardial infarction.
Channer
K S
KS
Department of Cardiology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. kevin.channer@csuh.nhs.uk
Pugh
P J
PJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D016207:Cytokines / Q000276:immunology; D004638:Emergency Treatment; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D011379:Prognosis; D015912:Thrombolytic Therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D016207:Cytokines; D002097:C-Reactive Protein; D001241:Aspirin